Pharmacological solutions in myopia control Recorded webinar
It is well known that atropine has an effect on myopia progression. Many formulations containing atropine are not currently available to optometrists without IP status, however it is important to be aware of these in order to fully inform patients and their parents.
Does pupil dilation exist, and if so, what is the impact of this when prescribing or dispensing spectacles?
This presentation will highlight the dose-dependence complication and effectivity of ultra-low dose atropine and how this might integrate with the need for vision correction. We will review the long standing but evolving COMET based studies and and new classes of pharmaceutical solutions that are currently being trialled.
CET Points: 1
CETpoints.com credits: 1
Expiry Date: 31/12/2021
Also accepted by
What's new in glaucoma?
This lecture will consider the latest developments in glaucoma clinics, including diagnostic technology and treatment options.
Spectacle Lenses in Myopia Control
This presentation will discuss practice-based methods of customising the spectacle lens option to reduce myopic progression and prevent pathologies associated with myopic extension of the eye.